Allergy Therapeutics (AGY)

 

Latest News

All resolutions passed at AGM of Allergy Therapeutics

Allergy Therapeutics has announced that all resolutions were passed by shareholders at today's Annual General Meeting. A...

Result of AGM

RNS Number: 2447X Allergy Therapeutics PLC 22 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Result of Annual General Meeting 22 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces that, at its Annual General Meeting held this m...

Block Listing Application

RNS Number: 0383X Allergy Therapeutics PLC 21 November 2017 21 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Block Listing Application Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that an application has been made to the London Stoc...

Allergy Therapeutics to Present at Jefferies 2017

RNS Number: 2495W Allergy Therapeutics PLC 13 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics to Present at Jefferies 2017 London Healthcare Conference 13 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces th...

All News

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account